E.K. Mberu

Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in <i>Plasmodium falciparum</i> : Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites

Alexis Nzila, E.K. Mberu, J. Sulo et al. · Antimicrobial Agents and Chemotherapy · 2000 · 231 citations · Full text

Double Mutant Dhps, Antiparasitic Agent, Malaria +20

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

Theonest K. Mutabingwa, Alexis Nzila, E.K. Mberu et al. · The Lancet · 2001 · 179 citations

Antiparasitic Agent, Medicine, Malaria +4

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

W.M. Watkins, E.K. Mberu, PA Winstanley et al. · Parasitology Today · 1997 · 155 citations

Predictive Model, Pharmacological Study, Antiparasitic Agent +10

Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on Kenyan<i>Plasmodium falciparum</i>

Alexis Nzila, Eunice Nduati, E.K. Mberu et al. · The Journal of Infectious Diseases · 2000 · 135 citations · Full text

Antiparasitic Agent, Malaria, Pharmacotherapy +19

Potent antimalarial activity of the alkaloid nitidine, isolated from a Kenyan herbal remedy

D M Gakunju, E.K. Mberu, S. F. Dossaji et al. · Antimicrobial Agents and Chemotherapy · 1995 · 124 citations

Antiparasitic Agent, Malaria, Toddalia Asiatica +18